Literature DB >> 16546209

Crystal structure and site 1 binding energetics of human placental lactogen.

Scott T R Walsh1, Anthony A Kossiakoff.   

Abstract

In primates, placental lactogen (PL) is a pituitary hormone with fundamental roles during pregnancy involving fetal growth, metabolism, and stimulating lactation in the mother. Human placental lactogen (hPL) is highly conserved with human growth hormone (hGH) and both hormones bind to the hPRLR extracellular domain (ECD), the first step in receptor homodimerization, in a Zn2+-dependent manner. A modified surface plasmon resonance method was developed to measure the kinetics for hPL and hGH binding to the hPRLR ECD, with and without Zn2+ and showed that hPL has about a tenfold higher affinity for the hPRLR ECD1 than hGH. The crystal structure of the free state of hPL has been determined to 2.0 A resolution showing the molecule possesses an overall structure similar to other long chain four-helix bundle cytokines. Comparison of the free hPL structure with the 1:1 complex structure of hGH bound to the hPRLR ECD1 suggests that two surface loops undergo conformational changes >10 A upon binding. An 18 residue Ala-scan was used to characterize the binding energy epitope for the site 1 interface of hPL. Individual alanine substitutions at five positions reduced binding affinity by a DeltaDeltaG > or = 3 kcal mol(-1). A comparison of the hPL site 1 epitope with that previously determined for hGH indicates contributions of individual residues track reasonably well between hPL and hGH. In particular, residues involved in the zinc-binding site and Lys172 constitute the principal binding determinants for both hormones. However, several residues that are identical between hPL and hGH contribute quite differently to the binding of the hPRLR ECD1. Additionally, the overall magnitudes of the DeltaDeltaG changes observed from the Ala-scan of hPL were markedly larger than those determined in the comparative scan of hGH to the hPRLR ECD1. The structural and biophysical data presented here show that subtle changes in the structural context of an interaction can lead to significantly different effects at the individual residue level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546209     DOI: 10.1016/j.jmb.2006.02.038

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Zinc binding to human lactogenic hormones and the human prolactin receptor.

Authors:  Jeffrey L Voorhees; Geeta Vittal Rao; Timothy J Gordon; Charles L Brooks
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

2.  Obligate ordered binding of human lactogenic cytokines.

Authors:  Jeffery L Voorhees; Charles L Brooks
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

3.  Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity.

Authors:  Karthik M Sundaram; Yilin Zhang; Anirban K Mitra; Jean-Louis K Kouadio; Katja Gwin; Anthony A Kossiakoff; Brian B Roman; Ernst Lengyel; Joseph A Piccirilli
Journal:  Cancer Res       Date:  2017-02-15       Impact factor: 12.701

4.  Reduced cell invasion may be a characteristic of placental defects in pregnant women of advanced maternal age at single-cell level.

Authors:  Bin Zhang; Feng Zhang; Fengying Lu; Jing Wang; Wenbai Zhou; Huihui Wang; Bin Yu
Journal:  J Zhejiang Univ Sci B       Date:  2022 Sept 15       Impact factor: 5.552

Review 5.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 6.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

7.  Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling.

Authors:  Shahir S Rizk; Jean-Louis K Kouadio; Anna Szymborska; Erica M Duguid; Somnath Mukherjee; Jiamao Zheng; Charles V Clevenger; Anthony A Kossiakoff
Journal:  Cell Commun Signal       Date:  2015-01-15       Impact factor: 5.712

8.  Modeling and fitting protein-protein complexes to predict change of binding energy.

Authors:  Daniel F A R Dourado; Samuel Coulbourn Flores
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

9.  Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy.

Authors:  Mohammad Sajjad Ghaemi; Daniel B DiGiulio; Kévin Contrepois; Benjamin Callahan; Thuy T M Ngo; Brittany Lee-McMullen; Benoit Lehallier; Anna Robaczewska; David Mcilwain; Yael Rosenberg-Hasson; Ronald J Wong; Cecele Quaintance; Anthony Culos; Natalie Stanley; Athena Tanada; Amy Tsai; Dyani Gaudilliere; Edward Ganio; Xiaoyuan Han; Kazuo Ando; Leslie McNeil; Martha Tingle; Paul Wise; Ivana Maric; Marina Sirota; Tony Wyss-Coray; Virginia D Winn; Maurice L Druzin; Ronald Gibbs; Gary L Darmstadt; David B Lewis; Vahid Partovi Nia; Bruno Agard; Robert Tibshirani; Garry Nolan; Michael P Snyder; David A Relman; Stephen R Quake; Gary M Shaw; David K Stevenson; Martin S Angst; Brice Gaudilliere; Nima Aghaeepour
Journal:  Bioinformatics       Date:  2019-01-01       Impact factor: 6.937

10.  Placental lactogen is expressed but is not translated into protein in breast cancer.

Authors:  Traci R Tuttle; Eric R Hugo; Wilson S Tong; Nira Ben-Jonathan
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.